Edward J. Roy, PhD
Affiliations: | University of Illinois, Urbana-Champaign, Urbana-Champaign, IL |
Area:
glioma immunotherapyGoogle:
"Edward Roy"Mean distance: 13.79 (cluster 19) | S | N | B | C | P |
Parents
Sign in to add mentorGeorge Wade | grad student | 1972-1976 | U Mass Amherst |
Bruce S. McEwen | post-doc | 1976-1979 | Rockefeller |
Children
Sign in to add traineeAnn S. Clark | grad student | Dartmouth | |
Marlene Wilson | grad student | University of South Carolina School of Medicine | |
Cheryl D. Conrad | grad student | 1987-1994 | UIUC |
Ute Gawlick | grad student | 2005 | UIUC |
Timothy M. Fan | grad student | 2007 | UIUC |
Brent Alan Orr | grad student | 2007 | UIUC |
Diana L. Thomas | grad student | 2010 | UIUC |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ranoa DRE, Sharma P, Schane CP, et al. (2023) Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model. Journal For Immunotherapy of Cancer. 11 |
Boudreau MW, Duraki D, Wang L, et al. (2021) A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice. Science Translational Medicine. 13 |
Tang B, Guo ZS, Bartlett DL, et al. (2020) Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Duraki D, Boudreau MW, Wang L, et al. (2020) OR05-05 Lethal ERα-Dependent Hyperactivation of the Unfolded Protein Response Induces Complete Regression Without Recurrence of Primary and Metastatic Breast Cancer Journal of the Endocrine Society. 4 |
Sharma P, Marada VV, Kizerwetter M, et al. (2020) Abstract 3238: Engineering chimeric antigen receptors for adoptive T cell therapy of cancers that express the Tn antigen Immunology |
Tang B, Schane C, Shisler J, et al. (2019) Abstract A219: Using poxvirus to improve immunotherapy for brain glioma Cancer Immunology Research. 7 |
Tang B, Guo ZS, Bartlett DL, et al. (2019) Abstract 2264: Synergistic combination of oncolytic virotherapy and immunotherapy for glioma Cancer Research. 79: 2264-2264 |
Kowalsky SJ, Liu Z, Feist M, et al. (2018) Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Tosic V, Thomas DL, Kranz DM, et al. (2014) Myxoma virus expressing a fusion protein of interleukin-15 (IL15) and IL15 receptor alpha has enhanced antitumor activity. Plos One. 9: e109801 |
Stone JD, Harris DT, Soto CM, et al. (2014) A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control. Cancer Immunology, Immunotherapy : Cii. 63: 1163-76 |